Skip to main content
. 2020 Oct 28;10(11):875. doi: 10.3390/diagnostics10110875

Table 2.

Clinical Characteristics of Patients with CAD and Healthy Controls.

Characteristics Patients with CAD (n = 16) Healthy Controls (n = 16) p Value
Age (years) 61.5 ± 11.6 46.1 ± 10.8 <0.001
Male Gender (X) 16 12 0.013
Framingham Score 14.2 ± 7.7 8.1 ± 7.9 0.016
CACS 518.9 ± 631.6 0 0.001
Systolic Blood Pressure 129.8 ± 13.9 122.5 ± 22.1 0.326
Type 2 Diabetes (n) 5 (29%) 2 (12.5%) 0.124
Dyslipidemia (n) 11 (65%) 5 (31%) 0.029
CHF (n) 1 (6%) 0 0.17
Active Smoker (n) 7 (41%) 9 (56%) 0.283
Total Cholesterol 173.2 ± 42.2 193.8 ± 45.1 0.098
LDL-Cholesterol 98.6 ± 40.5 116.4 ± 35.4 0.169
HDL-Cholesterol 45.9 ± 15.1 37.4 ± 17.7 0.075
Medications (n)
Antiplatelet 8 (47%) 1 (6%) 0.004
β-Blockers 8 (47%) 2 (12.5%) 0.016
Stain 9 (53%) 8 (50%) 0.435
ACE or ARB 9 (53%) 3 (19%) 0.045
Calcium Channel Blocker 4 (24%) 2 (12.5%) 0.214

CACS: coronary artery calcium scoring.